Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.
Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check26 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check41 days agoChange DetectedThe website has transitioned from a 'Recruiting' status to 'Active, not recruiting' as of November 21, 2024, indicating a significant change in the availability of studies.SummaryDifference15%
- Check55 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links including those to HHS, NIH, and NLM, while removing the previous version 2.12.1.SummaryDifference17%
- Check62 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.